Literature DB >> 8130654

Pro-carboxypeptidase R cleaves bradykinin following activation.

T Shinohara1, C Sakurada, T Suzuki, O Takeuchi, W Campbell, S Ikeda, N Okada, H Okada.   

Abstract

Arginine carboxypeptidase (CPR) is a labile enzyme present in human serum which is unrelated to carboxypeptidase N. In this study we demonstrate that CPR exists in a precursor form in plasma and can be converted to the active form by trypsin and presumable trypsin-like enzymes. The trypsin-generated active form can not only cleave a small synthetic substrate, hippuryl-L-arginine, but can remove terminal arginine from bradykinin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8130654     DOI: 10.1159/000236661

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  8 in total

1.  Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.

Authors:  Mariko Nagashima; Zheng-Feng Yin; Lei Zhao; Kathy White; Yanhong Zhu; Nina Lasky; Meredith Halks-Miller; George J Broze; William P Fay; John Morser
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates.

Authors:  Zuzana Valnickova; Laura Sanglas; Joan L Arolas; Steen V Petersen; Christine Schar; Daniel Otzen; Francesc X Aviles; F Xavier Gomis-Rüth; Jan J Enghild
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

3.  Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.

Authors:  Toshihiko Nishimura; Timothy Myles; Adrian M Piliponsky; Adrian M Piliposky; Peter N Kao; Gerald J Berry; Lawrence L K Leung
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

4.  The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.

Authors:  Chengliang Wu; Paul Y Kim; Reg Manuel; Marian Seto; Marc Whitlow; Mariko Nagashima; John Morser; Ann Gils; Paul Declerck; Michael E Nesheim
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

Review 5.  Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

Authors:  J L Willemse; E Heylen; M E Nesheim; D F Hendriks
Journal:  J Thromb Haemost       Date:  2009-08-28       Impact factor: 5.824

Review 6.  Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).

Authors:  Lawrence L K Leung; Timothy Myles; Toshihiko Nishimura; Jason J Song; William H Robinson
Journal:  Mol Immunol       Date:  2008-08-15       Impact factor: 4.407

7.  Alterations in the kallikrein-kinin system predict death after heart transplant.

Authors:  Nicholas P Giangreco; Guillaume Lebreton; Susan Restaino; Maryjane Farr; Emmanuel Zorn; Paolo C Colombo; Jignesh Patel; Rajesh Kumar Soni; Pascal Leprince; Jon Kobashigawa; Nicholas P Tatonetti; Barry M Fine
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

8.  Heat-induced hyperthermia impacts the follicular fluid proteome of the periovulatory follicle in lactating dairy cows.

Authors:  Louisa A Rispoli; J Lannett Edwards; Ky G Pohler; Stephen Russell; Richard I Somiari; Rebecca R Payton; F Neal Schrick
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.